Lethally irradiated mice were grafted with syngeneic bone marrow cells or left ungrafted. Mice of each group were injected with different hematopoietic cytokines for 5 consecutive days starting immediately after irradiation or left uninjected. The recovery of lymphoid tissues induced by hematopoietic cytokines 7 days after irradiation and bone marrow cell transplantation was comparable to that observed at days 21-28 in irradiated, bone marrow-grafted, but cytokine-uninjected mice. IL-11 or IL-6, in combination with IL-3, was able to hasten thymus, spleen and blood cell numbers and functions. SCF also displayed a detectable effect when used with IL-3. Conversely, the IL-6 superagonist K-7/D-6 was able, when injected alone, to induce significant recovery of thymus, spleen and blood cells. Thus, K-7/D-6 appears to be a most efficient cytokine for fast reconstitution of lymphoid tissues after irradiation and bone marrow transplantation. Bone Marrow Transplantation (2000) 25, 427-433.
ative treatments of the recipient has been used to reconstitute hematopoiesis. The HPC capable of long-term reconstitution are quiescent and slowly cycling bone marrow cells that form multiple colonies of mixed lineages only in the presence of bone marrow stromal cell-derived cytokines. 6 Thus, the use of hematopoietic cytokines together with bone marrow transplantation has been shown to hasten neutrophil and platelet recovery, suggesting that appropriate combinations of these factors may be used to promote full reconstitution of the hematopoietic compartment. [7] [8] [9] In the present work, we have compared the effects of hematopoietic cytokines, such as IL-3, IL-11, SCF, IL-6 and the IL-6 super-agonist K-7/D-6, on the repopulation of lymphoid organs and tissues of mice irradiated with a lethal dose of X-rays and reconstituted with syngeneic bone marrow cells. IL-3 is involved in blood cell formation, as it stimulates the survival and the proliferation of pluripotent stem cells and promotes colony formation by multipotential progenitor cells. 10, 11 IL-11 is a multifunctional hematopoietic cytokine capable of supporting the maintenance of multilineage hematopoiesis in long-term bone marrow cultures, the proliferation of an IL-6-dependent cell line, and the formation of megakaryocyte, platelet and neutrophil colonies. [12] [13] [14] SCF is a potent hematopoietic growth factor acting on both early stem cells and already differentiated cells, particularly mast cells, in the bone marrow. 15 IL-6 plays a primary role in hematopoiesis, as it regulates the differentiation of B cells, megakaryocytes and platelets. 16, 17 K-7/D-6 carries amino acid substitutions in two distinct regions of the wild-type IL-6 that participate in the interaction with IL-6R and shows a 70-fold increased binding affinity as compared to the wild-type molecule. 18, 19 The results herein provide evidence that it is possible to accelerate the repopulation of lymphoid tissues after lethal irradiation and bone marrow transplantation by using different combinations of hematopoietic cytokines, such as IL-3 and IL-11, or IL-3 and IL-6. IL-3 and SCF gave only marginal effects. K-7/D-6, conversely, was able even when used alone to induce a fast recovery of lymphoid tissues after irradiation and bone marrow transplantation, suggesting that it can be considered an excellent candidate for clinical applications. cells in 0.2 ml were intravenously injected into C57BL/6 Thy1.1 recipient mice, immediately after irradiation. Alternatively, T cells were removed from the bone marrow cell suspension by negative selection using the Macs system. Briefly, bone marrow cells were washed with PBS and incubated for 20 min on ice with goat anti-mouse Thy1.2 MoAb-coated MicroBeads (Miltenyi Biotech, BergischGladbach, Germany). One hundred l of MicroBeads were used for magnetic staining of 10 7 cells. After incubation with MicroBeads, cells were washed with PBS, resuspended in 500 l and applied to the top of a prefilled and washed A2 column (Miltenyi), provided with a G22 needle for flow regulation. Columns were washed with 2 ml of PBS. The negative fraction was collected and analyzed by cytofluorimetry for the presence of T cells.
Cytokine treatment
Irradiated mice were injected subcutaneously, once a day for 5 consecutive days starting immediately after irradiation, with 0.1 ml PBS, supplemented with 0.1% bovine serum albumin, alone or containing 8 g of murine recombinant IL-3 (320 g/kg/day), and/or 5 g of human recombinant IL-11 (200 g/kg/day), and/or 5 g of rat recombinant SCF, and/or 5 g of human recombinant wildtype IL-6 (200 g/kg/day), and/or 5 g of K-7/D-6. IL-3, provided by Genzyme (Cambridge, MA, USA), had a biological activity of 7 × 10 6 U/mg. IL-11, provided by Genetics Institute (Cambridge, MA, USA), had a biological activity of 2.3 × 10 7 U/mg. SCF, provided by Amgen (Thousand Oaks, CA, USA), was at the concentration of 1 mg/ml. Wild-type IL-6 or the IL-6 variant K-7/D-6, produced by IRBM (Pomezia, Rome, Italy), was injected together with 10 g/day of human soluble IL-6R (sIL-6R␣). K-7/D-6 is an IL-6 super-agonist displaying 70-fold higher affinity than wild-type IL-6 for sIL-6R␣. 18 20, 21 Cell culture Mice were individually tested. Mice were killed by decapitation, their thymuses and spleens were aseptically removed and single cell suspensions prepared. Cell cultures were performed in microtissue culture plates (Falcon 3040, Oxnard, CA, USA) in RPMI 1640 medium supplemented with 10% fetal calf serum (Flow Laboratories, Irvine, UK), 2 mm l-glutamine (GIBCO), 10 g/ml gentamycin (Shering, Kenilworth, NY, USA) and 2 × 10 −5 m 2-mercaptoethanol. This supplemented medium is hereafter referred to as complete medium.
Thymocyte mitotic response to Concanavalin A (ConA)
The number of cells per thymus was determined and then single thymocyte suspensions were cultured in triplicate at 37°C in a 5% CO 2 
Cytofluorimetric analysis of thymocytes
The reagents used to detect Thy1.1 and Thy1.2 antigens were anti-Thy1.1 fluorescein isothiocyanate (FITC)-conjugated and anti-Thy1.2 phycoerythrin (PE)-conjugated MoAbs (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Thymocytes (10 6 cells/100 l) were incubated with 4 l of a titrated mixture of the two MoAbs for 30 min on ice and finally washed with PBS. Samples were analyzed using a FACStar Plus (Becton Dickinson Immunocytometry Systems) flow cytometer with standard optical configuration. The argon laser was tuned at 488 nm, 200 mW power output. Fluorescence was collected in log mode. After color compensation adjustment, data were acquired in list mode with the FACStar Plus Research Software (Becton Dickinson Immunocytometry Systems). Low forward scatter signals were gated out and at least 10 000 events from viable cells were accumulated. Thy1.1/Thy1.2 subset analysis was carried out by quadrant analysis on the resulting cytograms.
Splenocyte mitotic responses to ConA and lipopolysaccharide (LPS)
The number of cells per spleen was determined and then single splenocyte suspensions were cultured in triplicate as described above for thymocytes. Briefly, each triplicate culture well contained 4 × 10 5 splenocytes in 0.2 ml complete medium alone or with 1 g ConA or 0.2 g LPS. Splenocyte cultures were harvested and processed as described for thymocyte cultures.
Hematological analyses
Erythrocyte and leukocyte counts were performed on blood individually collected by decapitation.
Statistical analysis
Two-tailed Student's t-test was carried out to evaluate the statistical significance of the difference between means. Significance levels: P Ͻ 0.05 (*); P Ͻ 0.01 (**); not significant (NS).
Results

Kinetics of the reconstitution of thymus and spleen cells after lethal irradiation and bone marrow transplantation
C57BL/6 Thy1.1 mice were whole-body exposed to 9.5 Gy and injected with different doses of bone marrow cells from C57BL/6 Thy1.2 mice, immediately after irradiation. Mice (six per group) were killed 7, 14, 21 or 28 days later. At 28 days, the survival was 60% after transplantation of 10 5 bone marrow cells; 70% after transplantation of 10 6 bone marrow cells and 100% after transplantation of 10 7 bone marrow cells. Results in Table 1 show thymus and spleen cell repopulation and mitotic responses. At day 7 after irradiation the cell count and mitotic responses in both thymus and spleen are negligible regardless of the injected cell Table 1 Recovery of the immune system after bone marrow transplantation Thereafter, the dose of 10 7 bone marrow cells was chosen to evaluate the effects of hematopoietic cytokines at 7 days after irradiation.
Effect of different cytokines on the reconstitution of thymus, spleen and blood cells after irradiation and bone marrow transplantation
C57BL/6 Thy1.1 mice were 9.5 Gy irradiated and injected with IL-3 and IL-11, or IL-3 and SCF, or IL-3 and IL-6, or K-7/D-6 alone, over a period of 5 consecutive days, starting immediately after irradiation. Alternatively, mice received whole bone marrow cells or T cell-depleted bone marrow cells from C57BL/6 Thy1.2 mice, alone or with the hematopoietic cytokines. Mice were killed 7 days later. Results in Table 2 show that irradiation 7 days prior to sacrifice markedly reduces the cell number in the thymus. Treatment of irradiated mice with cytokines is unable to improve the thymus cellularity. Injection of whole bone marrow cells or T cell-depleted bone marrow cells into irradiated mice is slightly effective but yields insufficient thymocyte numbers to perform all tests. However, the combination of whole bone marrow cells or T cell-depleted bone marrow cells with hematopoietic cytokines greatly increases the thymus cell number. In particular, IL-11 or IL-6 in combination with IL-3 was able to significantly accelerate the recovery of thymus cells, whereas SCF was only slightly effective. Conversely, K-7/D-6 was found to be a very efficient mol- Table 2 Thymocytes from lethally irradiated Thy1. ecule that was able, when used alone, to induce a significant recovery of thymus cells. In these experiments, almost all thymocytes are of donor type, but have not yet acquired full ability to respond to ConA. Table 3 shows the results obtained with spleen cells from these same mice. Lethal irradiation significantly reduces the spleen cell number and ability of splenocytes to respond to ConA and LPS. Injection of cytokines alone is ineffective on the recovery of these parameters. Bone marrow transplantation alone improves to some extent the cell number but not the mitotic responses. If, however, whole bone marrow cells are injected together with hematopoietic cytokines, spleen cell number and mitotic responses to ConA and LPS are greatly enhanced, and sometimes fully recovered. In particular, cytokine treatment with IL-3, together with IL-11 or with IL-6, induces recovery of cell numbers and functions in the spleen of these mice at day 7 to a similar extent to that observed (Table 1) at days 21-28 after irradiation and bone marrow transplantation. K-7/D-6 was very efficient as it induced significant recovery of spleen cell number and mitotic responses. SCF was found to have only negligible effects.
T cell contamination of bone marrow cells is 5% and can be reduced to 0.2% by treating bone marrow cells with anti-Thy1.2 MoAb. The removal of T cells from the bone marrow cell suspension before injection abrogates the cytokine effect on the mitotic response of splenocytes to ConA but not to LPS, suggesting that the effect observed with whole bone marrow cells results from amplification of the bone marrow-contaminating T cells rather than from fast stem cell migration to and maturation in the thymus and/or accelerated T cell migration to the spleen. Notably, in these experiments the removal of contaminating T cells had no influence on the cytokine effect on the thymus (Table 2 ). Blood cells from mice lethally irradiated and reconstituted with bone marrow cells, alone or together with hematopoietic cytokines, were examined and results are reported in Table 4 . The recovery of leukocyte counts is strongly accelerated by injection of IL-3 in combination with IL-11 or IL-6, whereas the combination with SCF is ineffective. K-7/D-6 alone was also able to induce significant recovery of leukocytes of mice lethally irradiated and reconstituted with whole bone marrow cells or T cell-depleted bone marrow cells. As to erythrocytes, the increase in cell number induced by bone marrow cells and cytokines may result from precursor regeneration as well as from other factors, such as hemoconcentration, affecting their compartment distribution.
Discussion
In the present paper we report the effects of different hematopoietic cytokines in mice given a lethal dose of X-rays and bone marrow transplantation. The combination of IL-3 with IL-11 or IL-6 was able to elicit significant therapeutic effects, whereas the combination of IL-3 with SCF was almost completely ineffective. Conversely, K-7/D-6 alone was able to promote rapid recovery of thymus and spleen cells after irradiation, being as potent as the combination of IL-3 and IL-11 and more potent than IL-3 in combination with IL-6. These effects of hematopoietic cytokines suggest that the bone marrow cell population used to reconstitute the irradiated mice contains cells which can be induced by hematopoietic cytokines to proliferate, colonize the lymphoid tissues and give rise to differentiated cells. It has been previously shown that optimal proliferation and differentiation of HPC require the co-stimulation by two or more growth factors. The finding that some early-acting
Bone Marrow Transplantation cytokines, when used alone, are able to support the survival of HPC without inducing their proliferation 22 suggests that they may induce the expression of receptors for other growth factors which are required for cell division. Similarly, the development of erythroid, megakaryocyte, monocyte, platelet or neutrophil colonies from HPC requires the combination of different cytokines.
HPC usually reside in the bone marrow for 2 or 3 weeks before migrating to the thymus, where they remain quiescent for another 10-14 days before cycling. 23 Thus, treatment of irradiated mice with hematopoietic cytokines significantly shortens the time required for the repopulation of the thymus by the injected bone marrow cells. Indeed, previous findings 24 suggest that early acting hematopoietic growth factors are able to reduce the time required by HPC to go through the G 1 phase of the cell cycle. The repopulation of the spleen after lethal irradiation and bone marrow transplantation follows different kinetics as compared to the thymus. Thus, both pluripotent stem cells and HPC present in the bone marrow cell suspension injected into irradiated mice reach the spleen through the circulation and there are induced to differentiate if hematopoietic growth factors are present. Moreover, our results indicate that the hematopo-
